Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

Verici Dx reports full-year growth in Tutivia revenues and FY25 final results

Verici Dx reported higher annual revenues, first Tutivia sales and continued commercial progress, alongside a post-period equity fundraise...

June 29, 2026

Ethtry reports strengthened balance sheet in 2025 results

Ethtry reported a 2025 loss of £619,270, while cash increased to £4.3 million following a £5.3 million fundraising, supporting its renewable energy strategy and post-year-end Ethereum treasury rollout...

June 26, 2026

Praxis Precision Medicines wins FDA Breakthrough Status for rare epilepsy treatment

Praxis Precision Medicines has received FDA Breakthrough Therapy Designation for elsunersen, adding momentum to a rare epilepsy programme held in Biotech Growth Trust’s portfolio...

June 25, 2026

Cizzle Bio targets earlier detection in gastric cancer

Cizzle Bio is targeting the gastric cancer diagnostic gap with DEX-G2, a blood test designed to support earlier detection where routine screening is limited...

June 25, 2026

Spire Healthcare Group Plc Spire Healthcare receives further extension to PUSU deadline

Spire Healthcare says discussions with Toscafund continue, with the Takeover Panel consenting to a further extension of the offer deadline...

June 25, 2026

Verici Dx secures New York State laboratory certification for Tutivia test

Verici Dx has obtained New York State clinical laboratory certification, completing authorisation for Tutivia across all 50 US states and the District of Columbia...

June 24, 2026

Dr Allan Syms on Cizzle Biotechnology’s CIZ1B US accreditation

Cizzle Biotechnology Executive Chairman Dr Allan Syms discusses the CIZ1B early lung cancer test gaining CLIA accreditation in the US, marking a shift towards commercial adoption, royalty revenues, and wider..

June 22, 2026

Healthspan becomes a clearer investment theme in preventive wellness

Healthspan is becoming a stronger investment theme as consumers focus on daily habits that support healthier ageing...

June 22, 2026

Genflow Biosciences to Attend BIO San Diego as Chairman Gad Berdugo Joins mRNA Panel

Genflow Biosciences will attend BIO San Diego, with chairman Gad Berdugo joining an mRNA panel...

June 20, 2026

GSK gains US FDA approval for oral cUTI antibiotic Utebzi

GSK has secured US FDA approval for Utebzi, an oral carbapenem antibiotic for certain adult patients with complicated urinary tract infections...

June 18, 2026

Cizzle Biotechnology US Launch Opens the Door to Lung Cancer Test Royalties (video)

Cizzle Biotechnology has reached a pivotal commercial milestone, with its CIZ1B lung cancer blood test now available for clinical use in the United States. Executive Chairman Dr Allan Syms discusses..

June 17, 2026

Syncona appoints Norman Crighton to the Board

Syncona has appointed Norman Crighton as a non-executive director, with committee roles and shareholder priorities outlined...

June 17, 2026

Genflow Biosciences to present SLAB study data at Animal Longevity Summit 2026

Genflow Biosciences has been invited to present data from its SLAB study at the Animal Longevity Summit in Toronto in October 2026...

June 17, 2026

Cizzle Biotechnology’s CIZ1B early lung cancer test gains CLIA accreditation in the US

Cizzle Biotechnology’s CIZ1B biomarker blood test has received CLIA accreditation at OmniHealth Diagnostics in Texas, enabling U.S. healthcare providers to order the early-stage lung cancer test...

June 16, 2026

Astrazeneca Plc gains US approval for Truqap in PTEN-deficient prostate cancer

Astrazeneca Plc has gained US approval for Truqap with abiraterone and prednisone in PTEN-deficient metastatic prostate cancer...

June 15, 2026

Cizzle Biotechnology secures US patent allowance for CIZ1B lung cancer biomarker test

Cizzle Biotechnology says the USPTO has allowed a patent application covering core methods used to measure its CIZ1B biomarker for early-stage lung cancer detection...

June 12, 2026

Verici Dx completes WRAP Retail Offer and raises additional gross proceeds

Verici Dx has completed its WRAP Retail Offer, raising approximately £0.19 million in additional gross proceeds and increasing total proceeds to about £2.6 million...

June 12, 2026

GSK receives orphan designations for momelotinib in VEXAS syndrome

GSK has received orphan drug designations for momelotinib in the US and EU for VEXAS syndrome, with phase II/III development planned...

June 12, 2026

Cizzle Bio targets a clear need in lung cancer screening

Cizzle Bio is advancing its CIZ1B blood test as a complementary tool designed to support earlier lung cancer detection and risk assessment...

June 11, 2026

Biotech Growth Trust reports strong one-year performance

Biotech Growth Trust PLC reported a 1-year NAV total return of 87.3% and share price total return of 82.7%, ahead of the benchmark’s 47.4%. Longer-term results were mixed, with 5-year..

June 11, 2026

News and Interview Alerts

Company Presentations

TEAM plc poised for future growth (VIDEO)

Pennant International Group Investor Presentation with CEO Philip Walker

Open Orphan Investor Presentation – 2021 a good year, 2022 will be a great year

Ferro-Alloy Resources Investor Presentation 2022

Q&As

Oriole Resources’s CFO outlines next steps at Mbe, Senala, and Bibemi (LON:ORR)

13 July 2026

Sintana Energy fully funded for multi-country drilling programme

9 July 2026

Thor Energy CEO Andrew Hume discusses HY-Range hydrogen results and seismic plans

9 July 2026

Time Finance CEO Ed Rimmer discusses record profit and lending book growth

8 July 2026

PowerPlay Media outlines AIM plans and sports media growth strategy

8 July 2026

Hardman & Co

ICG Enterprise Trust: Investor questions answered and 1HFY’27 results

14 October 2026

Neuberger Private Equity Partners Limited 1H’26 results: Foot on the accelerator

8 October 2026

Chesnara Plc: Acquisitions show immediate benefits

2 September 2026

Arbuthnot Banking Group Plc 1H’26: accelerating franchise growth

4 August 2026

Real Estate Credit Investments maintains dividend as credit remains resilient

3 August 2026

Green News

Ferro-Alloy Resources appoints Peter Secker as CEO

26 October 2026

Ilika launches ORKA brand for deep-sea battery systems

22 October 2026

Drax Group Shares Offer Significant Valuation Upside as Data Centre Opportunity Remains Intact, Says Longspur Research

13 October 2026

Ampeak Energy Director Buys 500,000 shares in market purchase

6 October 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

Oriole Resources: Mbe Step-Out Drilling Sets Up a Bigger Resource Moment (video)

Criterium Energy: Two Months From a Cash Flow Shift That Could Reframe the Entire Project (video)

Cora Gold: Fully Funded Sanankoro Moves From Development Story To Resource Growth Opportunity (video)

Corero Network Security: Why DDoS Defence Is Becoming Critical Infrastructure For The AI Era (video)

Cerillion plc: Record Orders, Omantel Win And A £271m Pipeline Point To A Bigger H2 (video)

The Diverse Income Trust: Gervais Williams Sees UK Income Stocks Moving From Resilience To Outperformance (video)

BrokerTalk

Norcros plc Strengthens European Growth Plans as Equity Development Retains 400p Fair Value

15 June 2026

Cora Gold Sanankoro Drilling Programme Highlights Resource Growth Potential, Cavendish

9 June 2026

Finseta FY25 Results Show Investment Year Progress, Shore Capital

9 June 2026

Meridian Holdings Expands Brand Reach and Serbia Presence, Says Zacks

9 June 2026

Global Opportunities Trust Research: Flexible strategy targets real returns and downside protection

3 June 2026

Funds

Real Estate Credit Investments reports 10.5% dividend yield and £5m Spanish loan commitment

28 October 2026

City Natural Resources Growth and Income PLC

City Natural Resources Growth and Income reports 76.6% annual NAV return

28 October 2026

Volta Finance generates €38m in interest income with 1.8x dividend cover

22 October 2026

Geiger Counter highlights strong uranium market fundamentals and growing nuclear demand

21 October 2026

City Natural Resources Chairman Christopher Casey outlines Tufton’s investment strategy

21 October 2026

View all Funds, Market Insights and news >>

FTSE 100 News

Lion Finance secures $118m IFC funding for Georgian MSMEs

8 October 2026

Tesco raises profit guidance as H1 operating profit and free cash flow increase

8 October 2026

IMI agrees €63m acquisition of iSMA CONTROLLI

7 October 2026

Shell raises Q3 integrated gas outlook as refining margins improve

7 October 2026

UK Broker Ratings

Cranswick PLC (CWK.L) Stock Analysis: Evaluating a 20.73% Upside Potential in Packaged Foods

28 October 2026

Coats Group PLC (COA.L) Stock Analysis: Strong Buy Ratings and 45% Potential Upside

28 October 2026

Bellway PLC (BWY.L): An Investor’s Insight into Growth Potential with a 21% Revenue Surge

28 October 2026

Chemring Group PLC (CHG.L) Investor Outlook: Exploring a 14.74% Potential Upside in the Aerospace & Defense Sector

28 October 2026

Close Brothers Group PLC (CBG.L): Analyst Ratings Signal a 34.63% Potential Upside

28 October 2026

Health

Verici Dx reports full-year growth in Tutivia revenues and FY25 final results

Verici Dx reported higher annual revenues, first Tutivia sales and continued commercial progress, alongside a post-period equity fundraise...

June 29, 2026

Ethtry reports strengthened balance sheet in 2025 results

June 26, 2026

Praxis Precision Medicines wins FDA Breakthrough Status for rare epilepsy treatment

Praxis Precision Medicines has received FDA Breakthrough Therapy Designation for elsunersen, adding momentum to a rare epilepsy programme held in Biotech Growth Trust’s portfolio...

June 25, 2026

Cizzle Bio targets earlier detection in gastric cancer

Cizzle Bio is targeting the gastric cancer diagnostic gap with DEX-G2, a blood test designed to support earlier detection where routine screening is limited...

June 25, 2026

Spire Healthcare Group Plc Spire Healthcare receives further extension to PUSU deadline

Spire Healthcare says discussions with Toscafund continue, with the Takeover Panel consenting to a further extension of the offer deadline...

June 25, 2026

Verici Dx secures New York State laboratory certification for Tutivia test

Verici Dx has obtained New York State clinical laboratory certification, completing authorisation for Tutivia across all 50 US states and the District of Columbia...

June 24, 2026

Dr Allan Syms on Cizzle Biotechnology’s CIZ1B US accreditation

June 22, 2026

Healthspan becomes a clearer investment theme in preventive wellness

Healthspan is becoming a stronger investment theme as consumers focus on daily habits that support healthier ageing...

June 22, 2026

Genflow Biosciences to Attend BIO San Diego as Chairman Gad Berdugo Joins mRNA Panel

Genflow Biosciences will attend BIO San Diego, with chairman Gad Berdugo joining an mRNA panel...

June 20, 2026

GSK gains US FDA approval for oral cUTI antibiotic Utebzi

GSK has secured US FDA approval for Utebzi, an oral carbapenem antibiotic for certain adult patients with complicated urinary tract infections...

June 18, 2026

Cizzle Biotechnology US Launch Opens the Door to Lung Cancer Test Royalties (video)

June 17, 2026

Syncona appoints Norman Crighton to the Board

Syncona has appointed Norman Crighton as a non-executive director, with committee roles and shareholder priorities outlined...

June 17, 2026

Genflow Biosciences to present SLAB study data at Animal Longevity Summit 2026

Genflow Biosciences has been invited to present data from its SLAB study at the Animal Longevity Summit in Toronto in October 2026...

June 17, 2026

Cizzle Biotechnology’s CIZ1B early lung cancer test gains CLIA accreditation in the US

Cizzle Biotechnology’s CIZ1B biomarker blood test has received CLIA accreditation at OmniHealth Diagnostics in Texas, enabling U.S. healthcare providers to order the early-stage lung cancer test...

June 16, 2026

Astrazeneca Plc gains US approval for Truqap in PTEN-deficient prostate cancer

Astrazeneca Plc has gained US approval for Truqap with abiraterone and prednisone in PTEN-deficient metastatic prostate cancer...

June 15, 2026

Cizzle Biotechnology secures US patent allowance for CIZ1B lung cancer biomarker test

Cizzle Biotechnology says the USPTO has allowed a patent application covering core methods used to measure its CIZ1B biomarker for early-stage lung cancer detection...

June 12, 2026

Verici Dx completes WRAP Retail Offer and raises additional gross proceeds

Verici Dx has completed its WRAP Retail Offer, raising approximately £0.19 million in additional gross proceeds and increasing total proceeds to about £2.6 million...

June 12, 2026

GSK receives orphan designations for momelotinib in VEXAS syndrome

GSK has received orphan drug designations for momelotinib in the US and EU for VEXAS syndrome, with phase II/III development planned...

June 12, 2026

Cizzle Bio targets a clear need in lung cancer screening

Cizzle Bio is advancing its CIZ1B blood test as a complementary tool designed to support earlier lung cancer detection and risk assessment...

June 11, 2026

Biotech Growth Trust reports strong one-year performance

Biotech Growth Trust PLC reported a 1-year NAV total return of 87.3% and share price total return of 82.7%, ahead of the benchmark’s 47.4%. Longer-term results were mixed, with 5-year NAV growth of 9.4% versus 33.6% for the benchmark...

June 11, 2026